| Authors: |
Guillot A; Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany., Winkler M; Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany., Silva Afonso M; Department of Fibrosis Biology, Gilead Sciences, Foster City, California, USA., Aggarwal A; Department of Nonclinical safety & Pathobiology, Gilead Sciences, Foster City, California, USA., Lopez D; Department of Research Data Sciences, Gilead Sciences, Foster City, California, USA., Berger H; Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany., Kohlhepp MS; Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany., Liu H; Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany., Özdirik B; Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany., Eschrich J; Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany., Ma J; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH, Bethesda, Maryland, USA., Peiseler M; Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany., Heymann F; Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany., Pendem S; Department of Fibrosis Biology, Gilead Sciences, Foster City, California, USA., Mahadevan S; Department of Nonclinical safety & Pathobiology, Gilead Sciences, Foster City, California, USA., Gao B; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH, Bethesda, Maryland, USA., Diehl L; Department of Nonclinical safety & Pathobiology, Gilead Sciences, Foster City, California, USA., Gupta R; Department of Fibrosis Biology, Gilead Sciences, Foster City, California, USA., Tacke F; Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany. |
